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Conclusions: Applying the described hypofractionated TMI (4 Gy dose 
per fraction) a dose reduction to the organs at risk ranged from 
18.67%-66.48% of the prescribed dose and the effective time for one 
radiation session was 1 hour and 15 minutes (including patient 
positioning and imaging). The tomotherapy direct field angles 
arrangement instead of using the helical intensity-modulated radiation 
has allowed minimizing the delivery error associated with the setup of 
the leg positioning, especially in horizontal direction. An additional 
benefit was the shorter irradiation time. A disadvantage of the direct 
technique was poor conformality, as a result of which the non-skeletal 
structures in legs (mostly muscles and vessels) received a higher dose 
in order to ensure hitting the target. In conclusion, the applied 4 Gy 
fractionation is feasible using TomoHD system and time-efficient in a 
busy radiotherapy department, requiring only a single patient setup a 
day on three consecutive days. Through hypofractionation, the 
biological equivalent dose is also effectively increased. Further 
observation of patients treated with this scheme is necessary to 
evaluate the treatment response. 
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Purpose/Objective: Data from the National Radiotherapy 
Implementation Group (NRIG) suggests that the provision of IMRT has 
improved from around 2% of patients in 2008 to around an estimated 
15% in 2012 (Cooper and Williams 2012). The objective of this survey 
was to determine how each centre currently carries out the quality 
assurance (QA) processes for these IMRT treatments. For the purposes 
of this survey IMRT is defined as inverse planned treatments and 
includes linac based, Tomotherapy and Cyberknife delivery. The aim 
was to collect information on equipment, approach and tolerances as 
well as how QA approaches may change in the future. 
Materials and Methods: The survey was web based, however a word 
version was also available. Questions were divided into the following 
categories: Background and equipment, machine tolerance and QA, 
machine based verification, software based verification, future plans. 
Results: 57 responses were received from 53 centres (4 centres 
answered separately for different systems). All centres use 6MV with 
27% also using 8, 10 or 15MV. 41% use dynamic delivery, 48% use step 
and shoot and 35% use VMAT with 11% using Tomotherapy. 82% are 
limiting the numbers they treat with 45% receiving extra funding for 
IMRT. 42% have developed their own tests for commissioning and QA. 
100% perform machine based measurements to check IMRT plans with 
66% measuring both point doses and dose distributions and the main 
burden falling on physics staff (94%). 74% perform machine based 
measurements for every patient, and 49% have changed their plan 
based on the results of the QA measurements. 63% perform software 
based calculations to check IMRT plans, with 88% being point doses, 
3% being dose distributions only and 9% being both. However 97% have 
never changed a plan based on the results of the calculated IMRT 
check. 73% of these calculations are performed by physicists with the 
remaining being undertaken by dosimetrists. 87% report that they 
intend to change their QA processes in the near future with 41% being 
who does the QA, 51% changing to a different measurement, 56% 
reducing the number of measurements and 41% stopping doing 
measurements altogether. 
Conclusions: All centres currently include machine based 
measurements in their QA processes. This is time consuming, taking 
up to 30 minutes per patient, even when batched. The majority have 
already started looking at other techniques and the trend is towards 
reduction of measurements and sharing of workload. 
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Purpose/Objective: Proton Therapy and Carbon Ion Therapy have 
shown very good and promising results for a number of indications. 
The synchrotrons used to date to accelerate light ions up to carbon 
are however very large and expensive. We have therefore developed 
efficient, compact, cost effective treatment units that can make light 
ions treatments available with less complexity and lower costs, for the 
benefit of more patients. The systems allow for five different light 
ions species for research and clinical use. There is promising potential 
in mixing light ions but to date a lack of facilities hinder such 
research.  
Materials and Methods: A new compact superconducting isochronous 
multiple-light-ion cyclotron has been designed by Sumitomo for 
Hydrogen (Protons), Helium Ions, Lithium Ions, Boron and Carbon Ions. 
The peak energy is >300 MeV/u and the maximum Boron range is 
about 26 cm. (≈20cm Carbon). In mixed-modality radiation therapy it 
is possible to simultaneously create a uniform distribution of 
biological effect, dose and radiation quality in the tumor volume. For 
instance, with Lithium in combination with Boron or Carbon ions, the 
Lithium ions are mainly used in the distal tumor region whereas Boron 
or Carbon ions are used closer to the patient surface. By this method 
the low LET plateau dose from Lithium is elevated significantly by 
Bragg peak Boron or Carbon ion dose delivery in the shallow tumor 
region. Pencil Beam Scanning delivery is used exclusively for maximum 
dose conformity to target volumes and minimized exposure to 
surrounding tissues and OAR.  
Results: An innovative layout and arrangement of treatment rooms 
and the relatively compact new cyclotron accelerator allows a 
significant cost reduction compared to previously built carbon ion 
treatment facilities such as HIMAC at NIRS in Chiba, Japan, HIT in 
Heidelberg, Germany and CNAO in Pavia, Italy. The overall facility 
cost and cost per Light Ions treatment room is less than the current 
market prices of proton-only facilities. High dose rates from the 
cyclotron, fast switching and continous line scanning as opposed to 
synchrotrons' intermittent beam and spot scanning techniques allow 
for shorter irradiation times and higher patient throughput. 
 Conclusions: The new light ions technology provides a compact and 
very efficient system for curative treatment of several common 
malignant tumors of:head and neck, lung, liver, prostate, bone/soft-
tissue sarcoma, cervix, and pelvis (Tsujii 2010). At a facility cost equal 
or less than today's proton-only facilities, combined with enhanced 
throughput, the cost per treatment is reduced.  
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Purpose/Objective: Stereotactic radiosurgery using frame-based 
positioning is a well-established technique for the treatment of benign 
and malignant lesions. By contrast, a new trend towards frameless 
systems using image-guided positioning techniques is gaining 
mainstream acceptance. This study was designed to compare the 
overall accuracy of the frameless with the frame-based radiosurgery 
technique and to evaluate the immobilization characteristics of a 
commercially available frameless mask, more specifically, the setup 
errors and the intrafraction motion, to the invasive fixation of the 
frame-based technique. 
Materials and Methods: Multiple hidden target tests(HTT) were 
performed to measure the overall accuracy of the two positioning 
techniques for radiosurgery (i.e. frameless using stereoscopicx-ray 
imaging and 6DOF registration/positioning and frame-based using 
invasive ring and localizer box). Forty patients with 66 brain 
metastases were enrolled for frameless stereotactic radiosurgery using 
X-ray imaging and a 6DOF robotic couch. To analyze the frameless 
characteristics positioning results were collected before and after 
treatment to assess patient setup error and intrafraction motion. The 
obtained data was bench marked to literature for comparison with 
frame-based techniques. 
